Skip to main navigation Skip to search Skip to main content

Quality of Shared Decision Making in Lung Cancer Screening: The Right Process, With the Right Partners, at the Right Time and Place

  • Claudia C. Dobler*
  • , David E. Midthun
  • , Victor M. Montori
  • *Corresponding author for this work

Research output: Contribution to journalComment/debate/opinionResearchpeer-review

Abstract

[Extract] When lung cancer screening with
low-dose computed tomography
(LDCT) was added as a Medicare
benefit in 2015, a lung cancer screening counseling and shared decision making (SDM) visit
before the initial screen was made a condition
for reimbursement. It was specified that SDM
should involve the use of decision aids and the
discussion of benefits and harms of proceeding
or not with screening (eg, false-positive findings
leading to unnecessary invasive investigations,
overdiagnosis, and radiation exposure).1 To be
eligible for reimbursement, a clinician (either a
physician or a qualified nonphysician practitioner, eg, a physician assistant, nurse practitioner, or clinical nurse specialist) needs to
conduct the consultation
Original languageEnglish
Pages (from-to)1612-1616
Number of pages5
JournalMayo Clinic Proceedings
Volume92
Issue number11
DOIs
Publication statusPublished - 1 Nov 2017
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Quality of Shared Decision Making in Lung Cancer Screening: The Right Process, With the Right Partners, at the Right Time and Place'. Together they form a unique fingerprint.

Cite this